ERBB2 and breast carcinoma: Furthermore, an analysis of MYC demonstrated that decreased MYC protein expression occurs for both luminal (p = 9.14 x 10−3) and HER2-positive (p = 9.03 x 10−2) breast cancers, Fig 2D.